Enveda Biosciences appoints industry leader Mark Deeg, M.D., Ph.D., as Chief Medical Officer – Business Wire
Enveda Biosciences today announced the appointment of industry leader Mark Deeg, M.D., Ph.D., as the company’s Chief Medical Officer. Dr. Deeg’s experience in drug discovery and development is an excellent complement to Enveda’s immediate goals and long-term vision. (Photo: Business Wire)
BOULDER, Colo.–(BUSINESS WIRE)–Enveda Biosciences today announced the appointment of Mark Deeg, M.D., Ph.D., as the company’s Chief Medical Officer. Dr. Deeg is a medical and pharmaceutical leader with broad experience developing drugs and digital therapeutics at companies from biopharma startups to pharmaceutical giants like Eli Lilly & Co., where he spent more than a decade.
“It’s an exciting time at Enveda and I’m grateful for the chance to join the team and help advance a growing number of interesting compounds”
“We are thrilled to welcome Mark Deeg to Enveda as our Chief Medical Officer,” said Viswa Colluru, Ph.D., founder and CEO of Enveda. “Mark’s experience in all phases…
The post Enveda Biosciences appoints industry leader Mark Deeg, M.D., Ph.D., as Chief Medical Officer – Business Wire first appeared on SEO, Marketing and Social News | OneSEOCompany.com.
source: https://news.oneseocompany.com/2022/10/25/enveda-biosciences-appoints-industry-leader-mark-deeg-md-phd-as-chief-medical-officer-business-wire_2022102534305.html
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.